Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Tuberous Sclerosis × Anticonvulsants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Seizures 1 Epilepsy 1 Cognitive Dysfunction 1

Interventions

Sirolimus 6 Everolimus 5 ganaxolone 1 dactolisib 1 Vigabatrin 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Propranolol 1 Aspirin 1 Anticonvulsants 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Peking Union Medical College Hospital

Phase 2 Unknown

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡